JPRN-UMIN000018860已完成未知
ong-Term Vascular Response to Everolimus-Eluting Stent: Five-year Follow-up Optical Coherence Tomography Study - Long-Term Vascular Response to Everolimus-Eluting Stent: Five-year Follow-up Optical Coherence Tomography Study
Department of Cardiology, Kokura Memorial Hospital0 个研究点目标入组 40 人开始时间: 2015年9月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients presented with acute coronary syndrome 2) index target lesions with coronary artery bypass graft 3) index target lesions with in-stent restenosis 4) left ventricular ejection fraction <30% 5) eGFR <30 ml/min/1.73m2 6) inability to give informed consent
研究者
相似试验
尚未招募
不适用
Vascular Response to Everolimus-eluting Bioresorbable Vascular Scaffold Implantation in patients with Diabetes Mellitusangina pectorisNL-OMON38428Erasmus MC, Universitair Medisch Centrum Rotterdam50
招募中
Unknown
Clinical effects of everolimus in the subjects with autism spectrum disprders (ASD) in relation to tuberous sclerosis.there are a few individuals with TSC with SEGA who exhibite ASD symptoms.JPRN-jRCT1090220258Kunio Yui20
进行中（未招募）
1 期
Introduction of everolimus is associated with a reduction in the dosage of calcineurine-inhibitors in patients with a pulmonary graft who suffer from a notable chronic renal insuffisance.Patient who received a pulmonary transplant and who show notable renale insuffisance (DFG < 50ml/min/1.73m²) which has been progressive over the last two years or chronical renal insuffisance which progresses fast (a los of >50% DGF in 3 months) and isotopical glomerural filtration < 45 ml/min.EUCTR2006-001945-32-BEB Erasme15
已完成
2 期
Efficacy and Safety of Everolimus in Patients with Unresectable or Metastatic Renal Cell Carcinomarenal cell carcinomaJPRN-UMIN000008769Tokyo Afinitor Clinical Trial Group - RCC(TACT-R)120
尚未招募
2 期
Efficacy and Safety of Everolimus in Patients with Non-Clear Cell Renal Cell Carcinomaon-clear cell renal cell carcinomaJPRN-UMIN000006248Yamaguchi University Graduate School of Medicine , Department of Urology10